发明名称 |
Manufacturing pharmaceutical agent in administrable or implantable form having controlled liberation of principle active compound, comprises mixing the compound to vector and subjecting the mixture to isostatic high pressure treatment |
摘要 |
Manufacturing a pharmaceutical agent (A) in an administrable or implantable form having controlled liberation of principle active compound (I) comprises: mixing (I) to a vector comprising one or more excipients; and subjecting the mixture to a treatment by isostatic high pressure (100-700 MPa) for 60 minutes. An independent claim is also included for (I). |
申请公布号 |
FR2872429(A1) |
申请公布日期 |
2006.01.06 |
申请号 |
FR20040007403 |
申请日期 |
2004.07.02 |
申请人 |
ELLIPSE PHARMACEUTICALS SOCIETE ANONYME |
发明人 |
LACAZE SAINT JEAN CATHERINE;GRISLAIN LUC;BERGUA THOMAS;BOUTIGNON FRANCOIS;DEMAZEAU GERARD;LARGETEAU ALAIN |
分类号 |
A61K9/22;A61K9/00;A61K9/16;A61K31/192;A61K38/28 |
主分类号 |
A61K9/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|